The acquisition of new goal-directed actions requires the encoding of action-outcome associations. At a neural level, this encoding has been hypothesized to involve a prefronto-striatal circuit extending between the prelimbic cortex (PL) and the posterior dorsomedial striatum (pDMS); however, no research identifying this pathway with any precision has been reported. We started by mapping the prelimbic input to the dorsal and ventral striatum using a combination of retrograde and anterograde tracing with CLARITY and established that PL-pDMS projections share some overlap with projections to the nucleus accumbens core (NAc) in rats. We then tested whether each of these pathways were functionally required for goal-directed learning; we used a pathway-specific dual-virus chemogenetic approach to selectively silence pDMS-projecting or NAc-projecting PL neurons during instrumental training and tested rats for goal-directed action. We found that silencing PLpDMS projections abolished goal-directed learning, whereas silencing PL-NAc projections left goaldirected learning intact. Finally, we used a three-virus approach to silence bilateral and contralateral pDMSprojecting PL neurons and again blocked goaldirected learning. These results establish that the acquisition of new goal-directed actions depends on the bilateral PL-pDMS pathway driven by intratelencephalic cortical neurons.
INTRODUCTION
Optimal action selection requires choosing actions that lead to advantageous outcomes while avoiding those that may lead to harm. In a changing environment, it is often necessary to choose actions based on their consequences, guided by associations between specific actions and their outcomes. This goal-directed action selection is cognitively demanding, and so when environmental conditions are stable, actions can become automatized as habits, guided by association between antecedent stimuli and the response and, therefore, independent of any specific outcome representation. Evidence from multiple species suggests that distinct corticostriatal circuits subserve the acquisition of goal-directed actions and habits [1] [2] [3] . Habits, in line with their stimulus-response control, involve connections between the sensorimotor cortices and the dorsolateral striatum (DLS) in rodents [4] or caudo-ventral putamen in humans [5] . Furthermore, as with many components of the motor system, the influence of this circuit on movement appears to be lateralized; e.g., unilateral lesions of DLS produce a deficit in stimulus-elicited responses contralateral to the lesion [6, 7] , whereas the strength of sensory cortex inputs to [8] , and plasticity in [9] , the DLS are correlated with the expression of responses contralateral to that input.
In contrast, there is substantial evidence to suggest that goaldirected actions depend on a circuit involving the prefrontal cortex and the dorsomedial striatum (DMS); particularly, in the rat, between the prelimbic cortex (PL) and the posterior DMS (i.e., pDMS). For example, bilateral lesions or inactivation of the PL [10] [11] [12] [13] or pDMS [14, 15] prevent the acquisition of goal-directed actions, and we have recently demonstrated that disconnection of these two structures-induced by contralateral lesions of each structure plus a lesion of the corpus callosum to disrupt contralateral projections-disrupts goal-directed learning [16] . Nevertheless, although it is now well established that goaldirected learning occurs in a circuit involving the PL and pDMS, because of the use of lesions in these prior experiments, it remains unclear whether this circuit involves the direct PLpDMS projection or an indirect connection involving some mediating structure. Furthermore, it remains unknown whether, like habits, goal-directed actions are encoded in lateralized corticostriatal circuits. In fact, there are several reasons to predict that goal-directed actions might differ from habits in this regard: first, the development of a motor skill is accompanied by an increase in effector specificity; whereas accuracy in a well-learned task is reliant on the specific effector (e.g., hand) with which it was acquired, recently acquired motor sequences can be executed with relatively similar accuracy with the left or right hand [17] . This suggests that lateralization of function develops as motor control transitions from a bilateral goal-directed circuit to a more lateralized habit circuit. Second, unlike habits, goaldirected actions are selected based on their consequences, and as such, their selection depends on comparing the relative values of alternative actions, something that would necessitate greater flexibility in action and effector representation (cf. [18] ). Third, goal-directed control depends on the ability to inhibit any pre-potent habitual response tendencies [19, 20] , and if habits are lateralized depending on effector, then, logically, to produce cohesive action, any inhibitory process must be bilateral. We have also shown [16] that rats with contralateral PL and pDMS lesions can acquire goal-directed actions if the corpus callosum is left intact, suggesting that the contralateral PL-pDMS projection is sufficient for goal-directed learning; however, because corpus callosum lesions also disrupt all other contralateral projections, direct pathway manipulations are required to demonstrate the specific role of the contralateral PL-pDMS pathway.
The predicted involvement of the bilateral prefronto-striatal projection in the acquisition of goal-directed action implies that this learning will involve bilaterally projecting cortical neurons. In the rodent, the PL sends glutamatergic projections to the striatum from two distinct subpopulations of projection neurons: pyramidal tract (PT) neurons, which project to the brainstem and generate ipsilateral collaterals in the striatum, and intratelencephalic (IT) neurons, which project bilaterally to the striatum via the corpus callosum [21, 22] . Our aim was to investigate the relative involvement of PT and IT projections in the acquisition of goal-directed action. We began by mapping the axonal pathway of PL projection neurons in an intact rat brain using the clear lipid-exchanged acrylamide-hybridized rigid imaging/immunostaining/in situ hybridization-compatible tissue hydrogel (CLARITY) tissue-clearing procedure [23] . Next, we sought to determine the extent of overlap between cortical projections to dorsal and ventral regions of the striatum; if dorsal corticostriatal projections, and not ventral corticostriatal projections, are specifically involved in goaldirected learning, then these two pathways must be somewhat distinct. We achieved this through a combination of anterograde and retrograde tracing, mapping ipsilateral and contralateral projections from the PL to the pDMS to the nucleus accumbens core (NAc) and from the PL to both regions. Next, we used goal-directed training and outcome devaluation tests to assess the functional role of PL projections to the pDMS and NAc in goal-directed learning. This was achieved using a dual-virus chemogenetic approach. We administered retrogradely transported adeno-associated virus (AAV)-Cre into the striatum and Credependent G i -coupled designer receptors exclusively activated by designer drugs (DREADDs) [24] , expressing the hM4Di receptor (DIO-hM4D), into the PL to bilaterally silence the PL-pDMS or PL-NAc pathway during instrumental training. These experiments confirmed that activity in the PL-pDMS pathway, but not the PLNAc pathway, was necessary for the acquisition of goal-directed action. Finally, we confirmed that the bilateral IT-mediated PLpDMS projection was specifically necessary for this learning using a three-virus approach to selectively silence only the contralaterally and bilaterally pDMS-projecting IT neurons in the PL.
RESULTS

Mapping Bilateral Prefronto-striatal Projections Anterograde Tracing with CLARITY
Tracing studies have demonstrated that the PL has bilateral projections to the dorsal and ventral striatum (e.g., [25] ). We used CLARITY tissue clearing [23] in an intact adult rat brain to map the axonal pathway of striatal projecting PL neurons into the ipsilateral striatum and across the corpus callosum (CC) into the contralateral striatum. Visualization of this pathway was achieved via a PL infusion of AAV-channelrhodopsin expressing enhanced yellow fluorescent protein (ChR2-eYFP); Figure 1A shows the ventral view of the dorsal half of the 3D-rendered CLARITY-cleared rat brain. High resolution imaging of IT projection fibers crossing the CC ( Figure 1B ) indicated that there were very few fibers in the dorsal or posterior regions of the CC. This was confirmed by tracing individual fibers ( Figure 1C ). In fact, fibers crossing the CC were almost all confined to the ventral, anterior part of the CC (see Video S1), confirming our previous findings [16] .
We then used a dual-virus approach to trace PL-pDMS projections by injecting a retrogradely transported AAV virus containing Cre recombinase (AAV-Cre) into the pDMS and Cre-dependent ChR2-eYFP (DIO-ChR2-eYFP) into the ipsilateral PL. Figure 1D shows the DIO-ChR2-eYFP injection site; these PL-pDMSprojecting neurons collateralize bilaterally in the NAc ( Figure 1E , insets) and maintain contralateral and ipsilateral projections to the pDMS ( Figure 1F , insets). A replication of these results is presented in Figure S1 .
Retrograde Tracing
Next, we used dual-retrograde tracing to estimate the proportion of ipsilateral versus contralateral projecting PL-pDMS and PLNAc neurons and the degree of overlap between these projections. Rats were injected with the retrograde tracers cholera toxin B subunit (CTB) and Fluoro-Gold (FG) unilaterally into the NAc ( Figure 1G ) and pDMS ( Figure 1H ). Retrograde labeling in the PL ( Figure 1I ) shows that projections to both dorsal and ventral striatum arise primarily from layer 5, with a strong ipsilateral projection to the NAc from layer 2 and a clear dorsoventral topographical organization (cf. [25] ). There were also co-labeled neurons (yellow, shown in insets), indicating that some neurons projected to both pDMS and NAc. We quantified ipsilateral, contralateral, and co-labeled neurons projecting to the pDMS ( Figures 1J and 1K ) and NAc ( Figures 1L and 1M) ; 5% of PLpDMS neurons ( Figure 1J ) and 9% of PL-NAc neurons ( Figure 1L ) projected to both regions. We found that a higher percentage of the contralateral PL-pDMS projection pathway sent collaterals to NAc ( Figure 1K , right bars) than the ipsilateral PL-pDMS pathway (left bars). Similarly, the contralateral PL-NAc pathway ( Figure 1M , right bars) sent the highest percentage of collaterals to the ipsilateral (pink bars) pDMS. These results suggest a small percentage (5%-15%) of PL corticostriatal neurons project to both pDMS and NAc, with more collaterals estimated within contralateral projecting (i.e., IT) corticostriatal neurons.
Silencing the PL-pDMS Pathway Prevents GoalDirected Learning
It has been demonstrated that goal-directed learning requires a circuit involving the PL and pDMS [16] . Here, we assessed whether the direct PL-pDMS projection is necessary for goaldirected learning. We infused AAV-Cre into the pDMS bilaterally and Cre-dependent hM4Di-DREADDs (DIO-hM4D) bilaterally into the PL (Figure 2A ) to selectively express hM4D-DREADDs on PL-pDMS neurons. Figure 2B shows AAV-Cre in the pDMS; the spread and location of AAV-Cre for all rats is shown in Figure S2A , with a map image showing AAV-Cre in a representative rat in Figure S2B . Figure 2C shows DIO-hM4D in the PL, and Figures S2C and S2D show the extent and distribution of DIO-hM4D expression in the PL of a representative rat.
In order to provide an estimate of the proportion of PLpDMS projection neurons infected with DIO-hM4D, we directly compared this to the number of neurons labeled using retrograde tracing. In a separate cohort of rats (Supplemental Experiment S1 in STAR Methods), we infused CTB and FG into the pDMS (one in each hemisphere; example shown in Figure S2E ) and quantified ipsilateral, contralateral, and bilateral PL-pDMS projection neurons in the PL. An example is shown in Figure S2F . The mean number of DIO-hM4D-infected neurons in the PL for each group is shown in Figure S2G . There were no significant differences between groups (p > 0.4). The mean number of retrograde (FG or CTB)-labeled PL neurons is presented in Figure S2H . There were significantly more ipsilateral than contralateral projections (p < 0.001) and more contralateral than bilateral projections (p < 0.001); however, it should be noted that this approach is biased toward underestimating the proportion of bilateral projections. Comparing these approaches, DIO-hM4D expression in the PL ranged from 30% to 45% of that achieved with retrograde labeling (DIO-hM4D = 42-60; FG/CTB = 134). It should also be noted that the tracing achieved using AAV-Cre and retrograde tracers differs qualitatively as well as quantitatively, and each approach may have a different propensity for uptake according to the specific properties or states of neurons.
We used in vitro recordings to confirm that the ligand of the hM4D receptor, clozapine N-oxide (CNO), suppressed neuronal firing in PL-pDMS projection neurons infected with DIO-hM4D. Figure 2D shows a biocytin-filled pDMS-projecting PL neuron. Under whole-cell current clamp, a constant current was applied to the cell to hold it at about À70 mV before drug superfusion. A family of voltage-current relationships was sampled by injection of incremental step current pulses. Figure 2E shows the number of evoked-action potentials (from the first depolarizing current injection step) before (black) and after (red) application of CNO in the same neurons. CNO significantly reduced excitability of neurons that were transfected with DIO-hM4D (paired t = 9.49; df = 4; p = 0.0007). Figure 2F shows representative raw traces belonging to the neuron in Figure 2D .
Rats were then trained and tested for goal-directed action. There were three groups, summarized in Figure 2G : all groups received AAV-Cre in the pDMS. There were two control groups; one group received DIO-hM4D into the PL and injections of vehicle during training (group hM4D+VEH), and the second group received a Cre-dependent control fluorophore in the PL and injections of CNO during training (group mCherry+CNO), thereby maintaining the PL-pDMS pathway in both conditions. The final group received DIO-hM4D in the PL and injections of CNO during instrumental training to silence all PL-pDMS projections (group hM4D+CNO). The summary of the behavioral design used in this experiment is presented in Figure 2H . Rats were given instrumental pre-training with two levers for a common outcome (Oc), after which they received 2 days of instrumental training under CNO or vehicle, in each of which both lever responses (R1 and R2) were paired with a novel outcome (O1 and O2). Pre-training data are shown in Figure S2I ; all groups showed a significant increase in press rate across days (linear trend F (1, 13) = 136.8; p < 0.0001), and there were no significant differences between groups (F < 2.5). Figure 2I shows the mean press rate across the two days of instrumental training; there were no significant differences between groups (F < 1.5).
In order to assess goal-directed actions, we gave rats an outcome devaluation test, drug free. As shown in Figure 2J , rats that had the PL-pDMS pathway silenced during instrumental training (group hM4D+CNO) failed to show outcome devaluation relative to the two control groups; group (hM4D+CNO versus rest) 3 devaluation (devalued versus valued) interaction (F (1, 13) = 5.2; p = 0.04). There were no differences between groups in overall response rates (highest F (1, 13) = 2.7; p = 0.1; group hM4D+VEH versus group mCherry+CNO). Follow-up simple effects analyses indicated that rats showed significantly greater responding on the valued relative to the devalued lever in group hM4D+VEH (p = 0.003) and group mCherry+CNO (p = 0.007), but there was no significant difference in group hM4D+CNO (p = 0.4), further confirming that silencing PLpDMS projections disrupted goal-directed learning.
Silencing the PL-NAc Pathway Leaves Goal-Directed Learning Intact
We have demonstrated that silencing PL-pDMS projections prevents goal-directed learning; however, we have also demonstrated that a proportion of PL-pDMS neurons (estimated between 5% and 15%) also collateralize in the NAc. We therefore assessed whether PL-NAc projections were likewise necessary for goal-directed learning. We targeted PL-NAc projections by infusing AAV-Cre into the NAc and DIO-hM4D into the PL (Figure 3A) . Figure 3B shows AAV-Cre in the NAc; the spread and location of AAV-Cre for all rats is shown in Figure S3A , with a map image showing AAV-Cre in a representative rat in Figure S3B . Figure 3C shows DIO-hM4D in the PL, and Figures  S3C and S3D show the extent of this DIO-hM4D expression in the PL. Figure S3E shows the mean number of DIO-hM4D-infected neurons in the PL for each group; expression of the control fluorophore (DIO-mCherry) was significantly greater than DIO-hM4D expression (F (1, 16) = 7.7; p = 0.014). Critically, there was no significant difference between group hM4D+VEH and group hM4D+CNO (F < 1.0). We compared the number of DIOhM4D-infected neurons to the number of PL-NAc projection neurons labeled retrogradely in Figure 1G . Because tracer injections were unilateral, they cannot estimate bilateral projections; however, there were significantly more ipsilateral than contralateral projections (p = 0.006; Figure S3F ). The extent of DIO-hM4D expression in the PL-NAc pathway ranged from 28% to 34% of retrograde labeling (DIO-hM4D = 37-45; FG/CTB = 135).
We again used in vitro recordings to confirm that CNO suppressed neuronal firing in DIO-hM4D-infected PL-NAc projec- tion neurons. Figure 3D shows a biocytinfilled PL-NAc neuron. Recordings were conducted as previously; Figure 3E shows the number of evoked-action potentials before (black) and after (red) application of CNO. CNO significantly reduced excitability of neurons that were transfected with DIO-hM4D (paired t = 6.33; df = 4; p = 0.003). Figure 3F shows representative raw traces from the neuron in Figure 3D .
Rats were trained and tested as summarized in Figure 2H . As previously, there were three groups, summarized in Figure 3G : two control groups, group hM4D+VEH and group mCherry+CNO, which each retained bilateral PL-NAc projections, and group hM4D+CNO, which had bilateral PL-NAc projections silenced during training. Rats showed a significant increase in instrumental responding across days during instrumental pre-training (linear trend F (1, 16) = 179; p < 0.0001), and there were no significant differences between groups (F < 2.5; Figure S3G ). Across instrumental training ( Figure 3H ), rats in group hM4D+CNO showed numerically lower response rates; however, this difference was not significant (F(1, 16) = 2.2; p = 0.2). All groups showed outcome devaluation ( Figure 3I ; (legend continued on next page) F (1, 16) = 55; p < 0.001), and there were no differences between groups in the magnitude of this effect (F < 1.5). There were also no differences between groups in overall rates of responding during test (F < 1.0). Follow-up simple effects analyses confirmed that rats showed significantly greater responding on the valued relative to devalued lever in group hM4D+VEH (p = 0.0005), in group mCherry+CNO (p = 0.003), and in group hM4D+CNO (p = 0.03), further confirming that silencing PLNAc projections during instrumental training spared goaldirected learning.
Silencing the Bilateral and Contralateral IT PL-pDMS Pathway Prevents Goal-Directed Learning
We have confirmed that the direct PL-pDMS projection pathway and not the PL-NAc pathway is necessary for goal-directed learning. In this final experiment, we specifically inactivated IT neurons projecting both contralaterally and bilaterally during instrumental training. We infused non-Cre-dependent hM4D-DREADDs unilaterally into the PL and AAV-Cre unilaterally into the pDMS of the same hemisphere, with DIO-hM4D infused into the PL of the contralateral hemisphere ( Figure 4A ). Using this preparation, we were able to silence all PL outputs from one hemisphere and just the contralateral and bilateral (IT) PLpDMS projections from the other hemisphere, leaving neurons projecting exclusively ipsilaterally intact. Figure 4B shows hM4D-DREADD in the PL; expression was reasonably well localized within the PL. Figure S4A shows a map of hM4D-DREADD expression in a representative rat. Staining for anti-GFP to enhance mCitrine additionally revealed the expression of GFP in neurons that expressed DIO-hM4D-mCherry, demonstrating the presence of the retrogradely transported AAV-Cre-GFP; Figures S4B-S4D show mCitrine/eGFP ( Figure S4B ), mCherry ( Figure S4C ), and the merged channels showing mCitrine in one hemisphere and mCherry/eGFP colocalized in the other hemisphere ( Figure S4D ). Importantly, the absence of mCherry in the contralateral PL ( Figure S4C ) indicates that the DIO-hM4D was not taken up by terminals and expressed retrogradely in IT neurons in the contralateral PL. The location and spread of hM4D-DREADDs for all rats is presented in Figure S4E , whereas Figure S4F shows the location and spread of AAV-Cre for all rats. Figure 4C shows DIO-hM4D in IT neurons in the PL. Figure S4G shows the mean number of DIO-hM4D-infected IT neurons in each group; there were no significant differences between groups (F < 1.5). The extent of DIO-hM4D infection in the PL ranged from 46% to 59% of contralateral and bilateral retrograde labeling achieved with FG and CTB ( Figure S2H ; DIO-hM4D = 22-28; FG/CTB = 48).
We again used in vitro recordings to verify that neurons expressing the hM4D-mCitrine-DREADDs were silenced by application of CNO. Figure 4D shows a biocytin-filled PL neuron expressing hM4D-DREADDs. Figure 4E shows the number of evoked-action potentials before and after application of CNO. CNO significantly reduced excitability of neurons that were transfected with hM4D-DREADD (paired t = 11.07; df = 5; p = 0.0001). Representative raw traces are depicted in Figure 4F , corresponding to the neuron shown in Figure 4D .
There were three groups with their respective treatments illustrated in Figure 4G : all rats received unilateral AAV-Cre into the pDMS and hM4D-mCitrine into the ipsilateral PL. Rats in group VEH received DIO-hM4D into the contralateral PL with injections of vehicle during training, leaving all projections intact; rats in group IPSI received DIO-mCherry in the contralateral PL and CNO during training to silence the PL ipsilaterally; and rats in group BILATERAL received DIO-hM4D along with CNO during training to silence all PL output from one hemisphere, and the contralateral and bilateral output from IT neurons in the PL of the other hemisphere, leaving only the ipsilateral PL-pDMS pathway intact in one hemisphere.
Rats were trained and tested as described in Figure 2H . They showed a significant increase in responding during instrumental pre-training (linear trend F (1, 21) = 148.0; p < 0.0001), and there were no significant differences between groups (F < 1.0; Figure S4H). Figure 4H shows the mean press rate across instrumental training; there were no differences between groups on day 1 (F < 1.5); however, whereas rats in group VEH and group IPSI showed an increase in responding on day 2, rats in Group BILATERAL failed to show such an increase, and this was confirmed by a significant main effect of group (BILATERAL versus the rest; F(1, 21) = 7; p = 0.02), a significant main effect of day (F(1, 21) = 20.9; p < 0.001), and a significant day 3 group (BILATERAL versus the rest) interaction (F(1, 21) = 9.2; p = 0.006). Follow-up simple effects analysis of responding on day 2 showed that there was a significant difference between group VEH and group BILATERAL (p = 0.003) and between group IPSI and group BILATERAL (p = 0.03), but not between group VEH and group IPSI (p = 0.2).
This difference was maintained on test ( Figure 4I ); rats in group BILATERAL responded significantly less overall than rats in groups VEH and IPSI (F (1, 21) = 18.6; p < 0.001). There was also a significant main effect of devaluation (F (1, 21) = 48.9; p < 0.001) and a significant group 3 devaluation interaction (BILATERAL versus the rest; F (1, 21) = 18.6; p = 0.001), indicating impaired outcome devaluation in group BILATERAL, relative to controls. We additionally assessed whether any impairment could be detected in group IPSI, but there was no significant difference in the magnitude of devaluation between group IPSI and group VEH (group 3 devaluation interaction; F (1, 21) = 1.6; p = 0.2). Furthermore, there was a significantly greater devaluation effect in group IPSI than group BILATERAL (interaction; F (1, 21) = 5.3; p = 0.03), indicating, therefore, that there was no impairment in group IPSI. Follow-up simple effects analyses further confirmed that there was a significant devaluation effect for group VEH (p < 0.0001) and group IPSI (p = 0.0001), but not for group BILATERAL (p = 0.19).
Due to the lower response rate in group BILATERAL, we looked at the minute-by-minute extinction data from each test to ensure that low rates of responding did not preclude detecting an effect. Response rates on valued and devalued levers over (H) Mean (± SEM) presses per minute averaged across each day of instrumental training for each group; *p < 0.05. (I) Mean total presses on valued and devalued lever for each rat in each group averaged across two 5-min devaluation tests; group means expressed as bars; *p < 0.05. Also see Figure S4 . the first and last minute of each test are presented in Figure S4I . We found a significant linear trend across time (F (1, 7) = 25.5; p = 0.001), indicating that response rates were sufficiently high at the start of test 1 to detect a difference, despite which no differences emerged at any time point (F < 1.5). Finally, we analyzed a subset of rats from group IPSI and group BILATERAL that were matched in their response rate across training. As shown in Figure S4J , although there were no significant differences between these matched groups across instrumental training (F < 1.0), the lower responders from group IPSI showed intact devaluation ( Figure S4K ; two-tailed t test t (6) = 5.7; p = 0.001), whereas, despite comparable performance during training, the matched rats from the BILATERAL group failed to show devaluation on test (t (4) = 1.5; p = 0.2). Together, these results confirm that the contralateral and bilateral PL-pDMS projections arising from IT neurons are required for goal-directed learning.
DISCUSSION
Goal-directed actions are the expression of learned associations between an action and the specific outcome it produces. The present experiments demonstrate that these associations are encoded in a bilateral prefronto-striatal circuit from the PL to the pDMS. We used a combination of anterograde and retrograde tracing to establish that PL projections to the pDMS and NAc were largely distinct; less than 15% of retrogradely labeled PL-pDMS neurons had collaterals in the NAc. We then used a dual-virus approach to silence the PL inputs to the pDMS arising from both IT and PT projections during instrumental training; this did not cause a radical change in motor performance but a much subtler change in what rats learned; i.e., they failed to encode the relationship between these actions and their specific consequences, indicated by a failure to show goal-directed responding at test. In contrast, silencing the PL-NAc projections using the same technique had a mild depressive effect on overall instrumental performance but left goal-directed learning intact. Finally, we demonstrated that goal-directed learning within the PL-pDMS pathway depends on bilateral projections from IT neurons in the PL. We used three viruses to silence the whole PL in one hemisphere and just the contralateral and bilateral (i.e., just the IT) PL projections in the other hemisphere during training, leaving intact only ipsilateral projections in a single hemisphere. Again, we found that this disrupted goal-directed learning and, furthermore, that the restoration of this pathway on test was not sufficient to restore goal-directed action.
The Bilateral PL-pDMS Pathway Mediates GoalDirected Learning One of the key findings of the present experiments is that PL input to the pDMS is specifically required during instrumental training for the subsequent expression of goal-directed action; rats lacking bilaterally projecting (i.e., IT) neurons during instrumental training failed to show goal-directed performance despite the restoration of that pathway on test. Consistent with this, prior studies have shown that PL lesions conducted before, but not after, training abolish goal-directed action [12, 13] , generally suggesting that the involvement of the PL input to the pDMS is transient and that these inputs produce long-term changes in the pDMS that mediate the subsequent expression of goal-directed learning on test. Indeed, instrumental training has been shown to increase the phosphorylation of mitogen-activated protein kinase (MAPK) (pMAPK/pERK) in pDMS medium spiny projection neurons [16, 26, 27] , which is necessary for goal-directed learning [26] , and we have shown that blocking the PL input to the pDMS prevents this increase [16] . Likewise, blocking MAPK phosphorylation in the PL immediately after instrumental training not only disrupts goal-directed learning, it also prevents the increase in pDMS pMAPK expression during an outcome devaluation test the following day [28] . Finally, and most critically, we have previously shown that bilateral disconnection of the PL and pDMS abolishes goal-directed action [16] . Taken together, these results suggest that the PL input to the pDMS is specifically required for learning new response-outcome contingencies rather than updating prior learning or interlacing new with existing learning, as has been attributed to the parafascicular thalamic inputs to the pDMS [29] .
An obvious question to emerge from the present results is precisely when during instrumental training PL inputs to the pDMS are required. For example, it remains unknown whether PL input to the pDMS is only necessary during action-outcome pairings or during the period of time after learning has occurred (i.e., consolidation). We have previously shown that instrumental trainingrelated plasticity in pDMS-projecting PL neurons occurs after a single session of instrumental training [28] , and this is reflected in an immediate and transient increase in pERK/pMAPK in layer 5, followed by a delayed (60 min after training) increase in pERK/pMAPK in layer 2 and 3 pDMS-projecting neurons, the latter of which are almost certainly IT neurons [30] . We hypothesized that these two anatomically and temporally distinct periods of activation reflected separate stages of goal-directed learning and consolidation, respectively, whereby within-session detection of the action-outcome contingency drives striatal activation through layer 5 and feeds back to layers 2 and 3 via thalamocortical projections [31, 32] , which feed back to the striatum directly and via layer 5 [28] . Within-session learning thus produces an immediate, transient increase in pERK/pMAPK in PL layer 5 and in the pDMS [28] , whereas consolidation is reflected in a delayed increase pERK/pMAPK in layers 2 and 3. Incorporating these findings into the current results, we suggest that the IT projection is involved in both goal-directed learning and consolidation, with the primary bilateral pathway originating from layer 5 involved in detection of the instrumental action-outcome contingency and driving immediate changes in plasticity in the pDMS and a second population of layer 2 and 3 neurons involved in the consolidation of this learning.
Distinct Corticostriatal Circuits Mediate Response Vigor and Goal-Directed Learning
A separate behavioral effect of PL disruption was a reduction in the rate of lever pressing, suggestive of a reduction in response vigor. This was particularly clear in the final experiment (Figure 4) , in which we observed that unilateral silencing of the PL in combination with contralateral silencing of IT projections resulted in reduced rates of instrumental responding during training and test. Nevertheless, we established that these lower rates of responding were not at such a level to prevent the detection of a response bias if one existed (see Figures S4I-S4K) . The general finding that PL inactivation produced a reduction in response vigor is not new; bilateral lesions of the PL have previously been reported to produce a reduction in response vigor [10] , as well as disrupting goal-directed learning. The present results, however, go some way toward establishing that the direct PL-pDMS projections are not specifically involved in maintaining vigor; when only the PL-pDMS projections were silenced (Figure 2) , rats responded at levels comparable to controls. Interestingly, disrupting PL-NAc projections produced a mild (though not significant) reduction in response vigor (Figure 3 ) and indeed produced similar response rates to those with unilateral PL plus IT PLpDMS silencing (Figure 4) . Therefore, it is likely that the reduction in response vigor observed when the whole PL was silenced in addition to the IT projections was induced by disruption of neuronal populations in addition to the direct PL-pDMS pathway, i.e., potentially the PL-NAc pathway, which, as established (Figure 1 ), has some overlap with PL-pDMS projections. Indeed, we have previously argued [33] that the ventral striatum is generally important for instrumental performance, and indeed, lesions of the NAc produce a marked reduction in response vigor, as well as in goal-directed action selection [34] [35] [36] . It is possible, therefore, that PL-NAc projections constitute a cortico-ventral striatal pathway responsible for regulating response vigor during goal-directed performance, which complements the dorsal PL-pDMS pathway that mediates the acquisition of goal-directed learning.
Bilateral Control of Goal-Directed Learning by IT Neurons
Interestingly, a number of theoretical and computational approaches have converged on the suggestion that goal-directed action is determined by the hierarchical interaction of associative learning and motor control processes (e.g., [37] [38] [39] [40] ). Generally, these accounts propose that the prefrontal cortex provides ''top-down'' modulation of output pathways, largely through its connections with circuits within the basal ganglia, to bias selection toward the appropriate action [22, 41] . Indeed, recent evidence suggests that IT neurons have a similar functional connection with both populations of striatal projection neurons [42], generally allowing for flexible bidirectional control of motor output, which appears to require activation of both populations [27, 43, 44] . However, it is also possible that silencing PLpDMS projections disrupts goal-directed learning by enhancing habitual response control. There is now substantial evidence to suggest that the associations underlying habits develop in parallel with those underlying goal-directed actions, and therefore, a failure in one system leads to response control by the other [15, 45] . Although possible, it is unclear how silencing PLpDMS projections could strengthen corticostriatal synapses encoding habits; there is now considerable evidence that, unlike goal-directed actions, habits are encoded in the DLS (e.g., [45] ), and there is emerging evidence that the associations underlying habitual actions are encoded in lateralized corticostriatal synapses that are stimulus and response specific [8] . We believe it is more likely that habits and goal-directed actions are encoded in distinct cortico-striatal projection pathways, with the former requiring lateralized cortical inputs to the DLS and the latter requiring bilateral PL inputs to the pDMS. This distinction aligns intuitively with their respective responsecontrol characteristics; whereas habits may be acquired and executed through the activation of a relatively restricted subpopulation of neurons in the DLS to drive a specific motor response, goal-directed actions rely on the capacity of animals to flexibly alter response strategy in line with changes in outcome value or contingency. In line with this distinction, IT neurons would be well placed to flexibly control the strength of the output in multiple populations of neurons in the pDMS bilaterally.
On this point, it is important to consider what role, if any, PT neurons may play in goal-directed learning. Although the present series of experiments cannot rule out a role for PT neurons in goal-directed learning, we have previously shown [16] that rats with contralateral lesions of the PL and pDMS, leaving exclusively contralateral PL-pDMS projections intact, are still able to acquire goal-directed actions. This suggests that whatever role PT neurons play in the processes underlying goal-directed learning, they are not necessary for the acquisition and expression of action-outcome associations. Interestingly, ipsilateral PL-pDMS projections have been implicated in attentional functions [46] and in tasks that require the use of higher-order cues as discriminative stimuli to modulate response selection [47] [48] [49] . Therefore, one possibility is that PT neurons are important for modulating response strategy under ambiguity, although it has also been reported [50] that such functions could be maintained by contralateral projections. It has alternatively been suggested that, whereas IT neurons are involved in action planning, PT neurons convey an efference copy of performed actions [51, 52] . Furthermore, the connectivity, and so the flow of information between IT and PT neurons, has been argued to be almost entirely unidirectional from IT to PT neurons [53] . Together, these findings suggest that IT neurons could serve to adjust PT output so as to regulate the expression of associations acquired by IT neurons, perhaps at the level of their common downstream target, the pDMS. Nevertheless, although their respective roles in controlling behavior have remained relatively poorly understood, the present results constitute a clear demonstration that IT neurons play a critical role in goal-directed learning, and developments enabling the independent manipulation of these neuronal circuits will undoubtedly continue to shed new light on these processes.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experiments were conducted with healthy, experimentally naive wild-type male outbred Long-Evans or Hooded Wistar rats aged between 8-16 weeks old prior to surgery. For all experiments, rats were housed in opaque plastic boxes of 2-4 in a climate controlled colony room and maintained on a 12 hr light/dark cycle (lights on at 7:00 am). All experimental stages occurred during the light portion. Water and standard lab chow were continuously available prior to the start of the experiment. For all experiments, rats were randomly assigned to experimental groups, ensuring that rats in the same box were divided into different groups. All experimental and surgical procedures were approved by the Animal Ethics Committee at the University of Sydney and the University of New South Wales, and are in accordance with the guidelines set out by the American Psychological Association for the treatment of animals in research. Specific details of rats in each experiment are provided below.
Anterograde tracing with CLARITY The subject was 1 male outbred Long-Evans rat (390 g prior to surgery) obtained from Monash University Animal Research Platform.
Anterograde dual-virus PL-pDMS tracing
The subjects were 2 male outbred Long-Evans rats (426-435 g prior to surgery) obtained from Animal Resources Centre (Canning Vale, WA).
Dual-retrograde PL-pDMS tracing
Subjects were 4 male outbred Long-Evans rats (383-470 g prior to surgery) obtained from Animal Resources Centre (Canning Vale, WA).
Silencing the PL-pDMS pathway Subjects were 24 male outbred Hooded Wistar rats (330-440 g prior to surgery) obtained from University of Adelaide Animal Research Platform.
Silencing the PL-NAc pathway Subjects were 31 male outbred Long Evans rats (380-450 g prior to surgery) obtained from the Animal Resources Centre (Canning Vale, WA).
Silencing the bilateral IT PL-pDMS pathway Subjects were 51 male outbred Long-Evans rats (350-470 g prior to surgery) obtained from the Animal Resources Centre (Canning Vale, WA).
Electrophysiology Recordings
Subjects were 9 male outbred Long-Evans rats (400-450 g prior to surgery) obtained from the Animal Resources Centre (Canning Vale, WA).
Experiment S1
Subjects were 20 male outbred Hooded Wistar rats (350-450 g prior to surgery) obtained from University of Adelaide Animal Research Platform.
METHOD DETAILS Surgery
For all experiments, rats were anaesthetized with 3% inhalant isoflurane gas with oxygen, delivered at a rate of 0.5L/min throughout surgery. Anaesthetized rats were placed in a stereotaxic frame (Kopf), and an incision was made down the midline of the skull, and the scalp was retracted to expose the skull. A 1.0 uL glass Hamilton syringe was lowered into the brain for infusions of viruses and tracers. Following infusions, rats were injected with a prophylactic (0.4 mL) dose of 300 mg/kg procaine penicillin immediately. Rats were given a minimum of 3 weeks of recovery time following surgery to allow sufficient viral and tracer expression. Surgical co-ordinates for each region were pre-determined from pilot studies and varied slightly between strains of rats. Channelrhodopsin, DREADDs or control fluorophores were infused into the PL at the co-ordinates (mm from bregma): A/P: +2. 
Viruses and Tracers
Cholera-Toxin B (CTB; List Biological Laboratories) was diluted to 1% in water, and Fluoro-Gold (FG; Fluorochrome) was diluted to 3% in saline. CTB was infused into the pDMS at total volume of 0.1 uL, and the NAc at total volume of 0.07 uL, whereas FG was infused into the pDMS at a total volume of 0.12 uL or NAc at a total volume of 0.1 uL, both injected at a rate of 0.05 uL/min with 2 min diffusion time. These volumes were selected based on pilot studies that were designed to equate the spread of CTB and FG in each region, and to achieve comparable spread to AAV-Cre.
Anterograde tracing of PL projections throughout the brain was obtained by injecting Channelrhodopsin, rAAV2/hSynChR2(H134R)-eYFP (ChR2-eYFP) or Cre-dependent Channelrhodopsin, rAAV5/EF1a-DIO-hChR2(H134R)-eYFP (DIO-ChR2-eYFP) into the PL. The total volume of infusion for both viruses was 0.3 uL at a rate of 0.1 uL/min, and the syringe was left in place for a further 2 min to allow for diffusion.
Corticostriatal pathways were targeted by infusing AAV-Cre (rAAV5.CMV.HI.eGFP-CRE.WPRE.SV40, UPenn) into the pDMS or NAc at a volume of 0.3 uL, and rate of 0.1 uL/min, the needle was left in place for a further 2 min for diffusion.
Projection neurons in the PL were targeted by infusing DIO-hM4D (rAAV5/hSyn-DIO-hM4D(Gi)-mCherry) or DIO-mCherry (rAAV5/ hSyn-DIO-mCherry) into the PL at a total volume of 0.75 uL and rate of 0.15 uL/min, with 2 min diffusion time. Silencing in the PL was achieved by infusing hM4D-DREADDs (AAV-hSyn-HA-hM4D(Gi)-IRES-mCitrine) into the PL at a total volume of 0.75 uL, and rate of 0.15 uL/min, with 2 min diffusion time. All DREADD viruses and control fluorophores were obtained from UNC Vector Core (Chapel Hill, NC, USA).
Drug
Clozapine-N-Oxide (CNO; National Institute of Mental Health Drug Supply Program, Rockville, MD, USA) was dissolved 0.8% HCl in water to a concentration of 7 mg/mL, and the pH was adjusted to 4.5. A solution of 0.1% HCl in water of the same pH was used as vehicle. Drug or vehicle was injected systemically (ip) 50 min prior to the onset of instrumental training, at a volume of 1 mL/kg, hence the dosage was 7 mg/kg.
Apparatus
For all behavioral experiments, training was conducted in 16 MED Associates operant chambers enclosed in sound-and light-attenuating cabinets. Each chamber was fitted with a pellet dispenser capable of delivering a 45 mg grain food pellet (Bioserve Biotechnologies), to a recessed magazine inside the chamber, as well as two pumps fitted with syringes outside the chamber, capable of delivering 0.2 mL of either 20% sucrose solution (white sugar, Coles, Australia) diluted in H 2 O or 20% maltodextrin solution (PolyJoule, Nutrica, Australia) diluted in H 2 O, each delivered to separate compartments of a recessed magazine inside the chamber.
The chambers also contained two retractable levers that could be inserted individually on the left and right sides of the magazine. Head entries into the magazine were detected via an infrared photobeam. Unless otherwise stated, the operant chambers were fully illuminated during all experimental stages, illumination was provided by a 3W, 24V house light located on the upper edge of the wall opposite to the magazine. All training sessions were pre-programmed on two computers located in a separate room through the MED Associates software (Med-PC), these computers also recorded the experimental data from each session.
Behavioral Protocol and Food Restriction
In order to minimize the possibility of receptor desensitization and downregulation as a consequence of repeated CNO administrations [54], we used a behavioral training design in which the instrumental responses were pre-trained prior to the critical instrumental training, which was given over two days under CNO or vehicle; this procedure has been demonstrated to produce stable baseline rates of responding, and therefore minimize variability in response rates across the two critical training days [14, 16] . Food restriction Rats underwent 4 days of food restriction prior to the onset of magazine training and this continued throughout the duration of the experiment. During this time, they received 5 mg of chow daily for the first two days, and 10 mg from the third day until the end of the experiment. Their weight was monitored daily to ensure it remained above 85% of their pre-surgery body weight at all times. Magazine training Rats were given two days of magazine training (Days 1 and 2) . Magazine training consisted of placing the rats in the experimental chambers, where they received 30 deliveries of 20% maltodextrin solution into the magazine, at random intervals of 60 s. Instrumental pre-training All instrumental pre-training sessions terminated once 30 outcomes had been earned, or after 60 min. On the morning of Day 3, all rats received instrumental training for maltodextrin on a continuous reinforcement schedule (every lever press was rewarded) with a single lever. A second identical session was conducted in the afternoon of same day with the other lever. On Day 4, rats again received two separate training sessions with maltodextrin on a random interval 15 s schedule (RI15; responses are rewarded following a lever press approximately once every 15 s). On Days 5 and 6, rats received identical training on RI30 (average interval between rewarded responses is 30 s) schedules. The order of lever presentations was counterbalanced within groups and across days for all subjects. Instrumental training Rats were given a small sample of each of the outcomes on Day 6, in order to reduce neophobia. On Days 7 and 8, rats received two instrumental training sessions (one per day) with two new outcomes (grain pellets and sucrose solution). Each lever/outcome was trained individually within the same session on an RI30 schedule, where each lever was extended for 2 3 10 min sessions in alternating fashion (i.e., 4 3 10 min sessions in total) separated by 1 min of time-out in which the levers were retracted and the house light turned off. Fifty minutes prior to each of these training days, rats were injected (ip) with either CNO or vehicle. The order of lever and outcome presentations were fully counterbalanced within each group.
Outcome Devaluation Tests
All rats received at least two 1-h pre-exposure sessions to the devaluation chambers during the pre-training phase. For the outcome devaluation tests, rats were placed a separate set of chambers (devaluation chambers) and provided with ad libitum access to one of the previously earned outcomes (pellets or sucrose solution) for 50 min. Rats were then immediately returned to the experimental chambers where they were given a choice test in extinction with both levers available for 5 min. This test was conducted twice (Days 9 and 10); once after devaluation of each outcome. If the rats' lever press performance is goal-directed and so based on the specific action-outcome associations encoded during training, then their performance should reflect the current relative value of their consequences; i.e., they should respond more on lever that, during training, had delivered the still-valued outcome, and avoid the lever that delivered the now-devalued outcome.
Anterograde tracing with CLARITY CLARITY tissue clearing Eight weeks after surgery, the rat was perfused and the brain processed according to the procedure described by [23] using a standard electrophoresis machine filled with Sodium Dodecyl Sulfate (SDS) clearing solution (see [23] for details). During clearing, the voltage was run at 10-60V, with the temperature maintained below 50 C. Once cleared, the brain was cut in half horizontally (approx.
mm ventral to bregma).
Immunofluorescence Staining All phases of tissue staining and rinsing took place inside an incubator set at 37 C. The dorsal hemisphere of the brain was rinsed for 3 days (1 rinse per day) with 1X phosphate buffered saline (PBS) with 0.1% Triton X-100 (Sigma-Aldrich). The tissue was then washed for 8 days with PBS and then placed in 5000 uL of rabbit anti-GFP (1:500, Invitrogen) diluted in 0.5 M sodium borate buffer (SB) and 0.1% Triton for 22 days. The brain was then rinsed in SB and 0.1% Triton for 5 days (1 rinse per day), and placed in 5000 uL of secondary; donkey-anti-rabbit Alexa 647 (1:500, Invitrogen) diluted in 0.5 M SB and 0.1% Triton for 21 days. Finally, the brain was rinsed in 0.5 M SB with 0.1% Triton for 4 days (1 rinse per day).
Confocal Imaging and processing
The stained brain was incubated in 85% glycerol with water at 37 C for 3 days, and mounted using the same glycerol as mounting medium. The brain was mounted between two coverslips, using blu-tac putty to form a chamber and kwik-sil to seal the chamber, as described by [23] .
Overview mapping of the tissue was performed on an automated confocal box microscope (Olympus Fluoview, FV10I) using a 10x objective NA 0.3 with a 3.1 mm free working distance, 1 airy unit and 13 um step size. Alexa 647 was excited with a 635 nm laser line and emission captured from 660 to 760 nm. For high resolution confocal maps, imaging was performed on a Leica DMI 6000 SP8 SMD MP using a 25x water objective NA 0.95 with a 2.5 mm free working distance, 1 airy unit and 1.19 um step size. Alexa 647 was excited with a 633 nm laser line and emission captured from 638 -731 nm.
Using Fiji imaging processing software (simple neurite tracer plugin), individual corticostriatal axon fibers that originate at the injection site were traced from overview z stack images. Individual fiber paths were then volumetrically filled and colored. Traced fiber path stacks were projected and reconstructed in 3D.
Anterograde dual-virus PL-pDMS tracing
Immunofluorescence Staining Six weeks after surgery, the rats were perfused with 4% paraformaldehyde, and the brains sliced on a vibratome at 40 um. Four sections each from the PL, NAc and pDMS of each rat were rinsed 3 times for 10 min each in 0.1 M PBS, then sections were submerged in a blocking solution, consisting of PBS with 0.5% Triton and 10% normal horse serum (NHS) for 2 hr at room temperature. Sections were then submerged in 800 uL of rabbit anti-GFP (1:1000) diluted in PBS with 0.2% Triton and 2% NHS for 48 hr at 4 C. Sections were then rinsed 3 times for 10 min in PBS, before being submerged in donkey-anti-rabbit Cy3 (1:1000, Jackson Laboratories), diluted in PBS with 0.2% Triton and 2% NHS for 2 hr at room temperature. Sections were washed twice with PBS and twice with PB for 10 min each, and mounted with Vectashield mounting medium (Vector Laboratories). Confocal Imaging and processing Whole slices were imaged on a confocal microscope (BX16WI, Olympus) with a 4x air objective, and images stitched together manually using image processing software (ImageJ, Fiji). Insets of the NAc and pDMS were taken separately with a 10x air objective.
Dual-retrograde tracing
Exclusions and group allocation Rats were randomly assigned to conditions; three rats received pDMS and NAc infusions in the same hemisphere; 2 rats received FG in pDMS and CTB in NAc and 1 rat received the opposite, all in the left hemisphere. One rat received infusions in contralateral hemispheres (FG in left pDMS, CTB in right NAc). Immunofluorescence Staining Four weeks after surgery, rats were perfused with 4% paraformaldehyde, and brains sliced on a vibratome at 40 um. Four sections from the PL, and three each from the NAc and pDMS from each rat were rinsed 3 times for 10 min each in 0.1 M PBS, then sections were submerged in a blocking solution, consisting of PBS with 0.5% Triton and 10% NHS for 2 hr at room temperature. Sections were then submerged in 800 uL of goat anti-CTB (1:2000, List Biological Laboratories) diluted in PBS with 0.2% Triton and 2% NHS for 48 hr at 4 C. Sections were then rinsed 3 times for 10 min in PBS, before being submerged in donkey-anti-goat Alexa 546 (1:1000, Invitrogen), diluted in PBS with 0.2% Triton and 2% NHS for 2 hr at room temperature. Sections were washed twice with PBS and twice with PB for 10 min each, and mounted from PB with Fluoromount mounting medium (Southern Biotech). Confocal Imaging and processing Placement of retrograde tracers in the pDMS and NAc was verified under a confocal microscope (BX16WI, Olympus) using the boundaries defined by [55] , and PL sections were imaged with a 10x objective, and imaging software (ImageJ, Fiji) was used to quantify total FG, CTB and co-labeled CTB and FG neurons.
Silencing the PL-pDMS pathway Exclusions and group allocation AAV-Cre was infused into the pDMS in all rats. Group hM4D+CNO and Group hM4D+VEH received PL infusions of DIO-hM4D, whereas Group mCherry+CNO received PL infusions of the control fluorophore, DIO-mCherry. Rats were randomly allocated to groups, ensuring that housing boxes were split up between groups. Placements of viral infusions and cell counts of mCherry expression in the PL were conducted by an experimenter who was blind to group allocation. Rats were excluded if there were fewer than an average of 13 infected neurons per mm 2 in the PL, or if there was substantial mCherry expression outside of Layer 5, or the pattern of mCherry expression was otherwise inconsistent with the PL-pDMS projection pathway. A total of 8 animals were excluded from the analysis due to misplaced pDMS or PL infusions. After exclusions, 16 animals remained in the analysis (Group hM4D+VEH, n = 5; Group mCherry+CNO, n = 5; Group hM4D+CNO, n = 6).
Histology and Immunofluorescence
Following the final outcome devaluation test, rats were perfused and brains were sliced on a vibratome coronally at 40 um. Four sections containing the pDMS, and two sections containing the PL (one anterior and one posterior), were mounted onto slides with Vectashield mounting medium (Vector Laboratories). Placement and spread of AAV-Cre in the pDMS was imaged using a 4x air objective, and DIO-hM4D-DREADD/mCherry expression in the PL was imaged in each hemisphere with a 10x air objective under a confocal fluorescent microscope (BX61WI, Olympus).
Cellular Quantification
Placement of pDMS AAV-Cre was mapped at its widest point onto a common template to indicate viral spread. Neurons in the PL expressing DIO-hM4D-mCherry or DIO-mCherry were quantified using imaging software (ImageJ Cell Counter). One anterior (Bregma +3.7 to +4.7) and one posterior (Bregma +3.0 to +3.7) section was quantified bilaterally, and mean number of PL neurons was calculated as an average per mm 2 .
Silencing the PL-NAc pathway Exclusions and group allocation AAV-Cre was infused into the NAc in all rats. Group hM4D+VEH and Group hM4D+CNO received PL infusions of DIO-hM4D-DREADD, whereas Group mCherry+CNO received PL infusions of DIO-mCherry. Rats were randomly allocated to groups, ensuring that housing boxes were split up between groups. Placements of viral infusions and cell counts of mCherry expression in the PL were conducted by an experimenter who was blind to group allocation. Rats were excluded if there were fewer than an average of 15 infected neurons per mm 2 in the PL, or if the pattern of mCherry expression was inconsistent with the PL-NAc projection pathway. A total of 12 animals were excluded from the experiment due to misplaced NAc or PL infusions. After exclusions, 19 animals remained in the analysis (Group hM4D+VEH, n = 6; Group mCherry+CNO, n = 8; Group hM4D+CNO, n = 5). Behavioral protocol and Food Restriction Details regarding the behavioral protocol were identical to that described, except that after two days of magazine training, rats were given an extra day of pre-training hence pre-training was a total of 5 days; 2 days of CRF (Days 3-4); 1 day of RI15 (Day 5) and 2 days of RI30 (Day 6-7). Instrumental training then commenced on Days 8-9 and outcome devaluation tests on Days 10-11. Histology and Immunofluorescence Rats were perfused and brains were sliced on a vibratome coronally at 40 um. Four sections containing the NAc, and two sections containing the PL (one anterior and one posterior), were mounted onto slides with Vectashield mounting medium (Vector Laboratories). Placement and spread of AAV-Cre in the NAc was imaged using a 4x air objective, and DIO-hM4D-DREADD/mCherry expression in the PL was imaged in each hemisphere with a 10x air objective under a confocal fluorescent microscope (BX61WI, Olympus). Cellular Quantification Placement of NAc AAV-Cre was mapped at its widest point onto a common template to indicate viral spread. Neurons in the PL expressing DIO-hM4D-mCherry or DIO-mCherry were quantified using imaging software (ImageJ Cell Counter). One anterior (Bregma +3.7 to +4.7) and one posterior (Bregma +3.0 to +3.7) section was quantified bilaterally, and mean number of PL neurons was calculated as an average per mm 2 .
Silencing the bilateral IT PL-pDMS pathway Exclusions and group allocation In all rats, AAV-Cre was infused into the pDMS unilaterally, and hM4D-DREADDs was infused into the PL unilaterally in the same hemisphere. Rats in Group VEH and Group BILATERAL additionally received PL infusions of DIO-hM4D into the contralateral hemisphere, whereas Group IPSI received PL infusions of a DIO-mCherry. Rats were randomly allocated to groups, ensuring that housing boxes were split up between groups. Placements of viral infusions and cell counts of mCherry expression in the PL were conducted by an experimenter who was blind to group allocation. Rats were excluded if there were fewer than an average of 10 infected neurons per mm 2 in the PL, or if there was substantial mCherry expression outside of Layer 5, or the pattern of mCherry expression was otherwise inconsistent with the pDMS projection pathway. A total of 27 animals were excluded from the experiment due to misplaced pDMS or PL infusions. After exclusions, 24 rats remained in the analysis (Group IPSI, n = 9; Group VEH, n = 7; Group BILATERAL, n = 8).
Histology and Immunofluorescence
Rats were perfused and brains were sliced on a vibratome coronally at 40 um. Four sections containing the pDMS were mounted onto slides with Vectashield mounting medium (Vector Laboratories). Placement and spread of AAV-Cre in the pDMS was imaged using a 4x air objective. Sections containing the PL were stained for verification of the placement of hM4D-DREADDs: Two sections from the PL were rinsed 3 times for 10 min each in 0.1 M PBS, then sections were submerged in a blocking solution, consisting of PBS with 0.5% Triton and 10% NHS for 2 hr at room temperature. Sections were then submerged in 400 uL of rabbit anti-GFP (1:1000) diluted in PBS with 0.2% Triton and 2% NHS for 48 hr at 4 C. Sections were then rinsed 3 times for 10 min in PBS, before being submerged in 400 uL donkey-anti-rabbit Alexa 488 (1:1000, Invitrogen), diluted in PBS with 0.2% Triton and 2% NHS for 2 hr at room temperature. Sections were washed twice with PBS and twice with PB for 10 min each, and mounted from PB using Vectashield mounting medium with DAPI (Vector Laboratories). Placement and spread of hM4D-DREADD mCitrine and DIO-hM4D-DREADD/mCherry in the PL was imaged with 4x and 10x air objectives with a confocal microscope (BX16WI). Cellular Quantification Placement of pDMS AAV-Cre and PL hM4D-DREADD was mapped at its widest point onto a common template to indicate viral spread. Neurons in the PL expressing DIO-hM4D-mCherry or DIO-mCherry were quantified using imaging software (ImageJ Cell Counter). One section (Bregma +3.2 to +3.7) was quantified unilaterally in each rat, and mean number of PL neurons was calculated as an average per mm 2 .
Electrophysiology Recordings
Exclusions and group allocation In 6 rats, AAV-Cre was infused into the pDMS (n = 3) or NAc (n = 3) bilaterally, and DIO-hM4D-DREADD was infused into the PL bilaterally. In another 3 rats, hM4D-DREADDs was infused into the PL bilaterally. Recordings were conducted in 5 neurons from 2 rats in the DIO-hM4D infected PL-pDMS neurons, and 5 neurons from 2 rats in DIO-hM4D infected PL-NAc neurons, and 6 neurons from 3 rats in hM4D-DREADDs infected PL neurons. Drugs Biocytin was purchased from Sigma-Aldrich (St. Louis, MO). Clozapine-N-oxide (CNO) from Tocris Bioscience (Bristol, UK) and made into 10 mM stock solution in water. Brain slice preparation Rats were killed under deep anesthesia (isoflurane 4% in air), and the brain was rapidly removed and cut on a vibratome in ice-cold oxygenated sucrose buffer containing (in mM): 241 sucrose, 28 NaHCO 3 , 11 glucose, 1.4 NaH 2 PO 4 , 3.3 KCl, 0.2 CaCl 2 , 7 MgCl 2 . Coronal brain slices (300 mm thick) containing the PL were sampled and maintained at 33 C in a submerged chamber containing physiological saline with composition (in mM): 126 NaCl, 2.5 KCl, 1.4 NaH 2 PO 4 , 1.2 MgCl 2 , 2.4 CaCl 2 , 11 glucose and 25 NaHCO 3 , and equilibrated with 95% O 2 and 5% CO 2 . Electrophysiological recording and post hoc histological analysis After equilibration for 1 h, slices were transferred to a recording chamber and neurons visualized under an upright microscope (BX50WI, Olympus, Shinjuku, Japan) using differential interference contrast (DIC) Dodt tube optics and mCitrine or mCherry fluorescence, and superfused continuously (1.5 mL/min) with oxygenated physiological saline at 33 C. Whole-cell patch-clamp recordings were made using electrodes (2-5 MU) containing internal solution (in mM): 115 K gluconate, 20 NaCl, 1 MgCl 2 , 10 HEPES, 11 EGTA, 5 Mg-ATP, and 0.33 Na-GTP, pH 7.3, osmolarity 285-290 mOsm/L. Biocytin (0.1%) was added to the internal solution for marking the sampled neurons during recording. Data acquisition was performed with a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA), connected to a Macintosh computer and interface ITC-18 (Instrutech, Long Island, NY). Liquid junction potentials of À10 mV were corrected. In current-clamp mode, membrane potentials were sampled at 5 kHz (low pass filter 2 kHz, Axograph X, Axograph, Berkeley, CA). Stock solution of drug was diluted to working concentration (10 uM) in the extracellular solution immediately before use and applied by continuous superfusion. Data from whole-cell recordings were only included in analyses if (1) the neurons appeared healthy under DIC on the monitor screen, and (2) action potential amplitudes were at least 69 mV measured under current-clamp mode, to ensure that only highly viable neurons were included.
Immediately after physiological recording, brain slices containing biocytin-filled neurons were fixed overnight in 4% paraformaldehyde/0.16 M phosphate buffer (PB) solution and then placed in 0.3% Triton X-100/PB for 3 d to permeabilize cells. Slices containing mCitrine were then placed in 10% NHS/PB for 1 hr before being incubated in primary chicken anti-GFP (1:1000; Aves Labs) for 2 d at 4
C to enhance signal of hM4D-DREADD-mCitrine. The slices were rinsed in PB and then in a one-step incubation containing both Alexa Fluor 488-conjugated donkey anti-chicken secondary antibody (1:500; Jackson Laboratories) and Alexa Fluor 647-conjugated Streptavidin (1:1000; Life Technologies) for 2 hr. For slices containing DIO-hM4D-DREADD-mCherry, biocytin staining was revealed by incubation of either AMCA-conjugated avidin (1:500; Vector Laboratory) or Alexa Fluor 488-conjugated Streptavidin (1:1000; Life Technologies) for 2 hr. Stained slices were rinsed in PB 3 times for 10 mins each, and mounted with Fluoromount-G mounting medium (Southern Biotech). Neurons were imaged under a confocal microscope (Fluoview FV1000 and BX61WI, Olympus).
Supplemental Experiment S1
This experiment used two retrograde tracers to label ipsilateral, bilateral and contralateral PL-pDMS projections. We did this to provide a comparison point for estimating the percentage of retrogradely labeled neurons in each pathway that are infected using dual-virus AAV-Cre and DIO-hM4D. Exclusions and group allocation All rats received an infusion of CTB in the pDMS in one hemisphere and FG in the pDMS in the contralateral hemisphere. Ten rats were excluded from the analysis due to misplaced tracer infusions, or labeling that was either too extensive or insufficient. This left a total of 10 rats in the final experiment. Histology and Immunofluorescence Two weeks after tracer injections, rats were perfused with 4% paraformaldehyde, and brains were sliced coronally at 30 um on a vibratome. One slice containing the PL (Bregma +3.2 to +3.7) and four slices containing the pDMS were collected and stained to verify location and spread of tracer injections, and to quantify FG and CTB expression in the PL. Sections were rinsed 3 times for 10 min in 0.1 M PBS, then submerged for 2 hr in PBS with 0.5% Triton and 10% NHS. Sections were then placed in 400 mL of rabbit anti-FluoroGold (1:1700, Millipore) and goat-anti-CTB (1:2000) diluted in 0.2% Triton and 2% NHS in PBS for 48 hr at 4 C. Sections were then rinsed 3 times for 10 min in PBS and then placed in 400 uL of donkey-anti-rabbit Alexa 488 and donkey-anti-goat Alexa 647 secondaries (Invitrogen) both at 1:1000 for 2 hr in PBS with 0.2% Triton and 2% NHS at room temperature. Sections were then rinsed twice more with PBS and twice with PB for 10 min each and mounted from PB using Vectashield mounting medium without DAPI (Vector Laboratories). A single image was taken of the PL per hemisphere on a confocal Microscope (BX16WI, Olympus) using a 10x air objective, and images were quantified for FG, CTB and co-labeled cells in the PL using imaging software (Fiji Cell Counter). Ipsilateral projections and contralateral projections (excluding bilateral projections) and bilateral projections were quantified bilaterally in each rat, and means were calculated as an average per mm 2 .
QUANTIFICATION AND STATISTICAL ANALYSIS
Group sizes in all experiments were selected based on our estimation of the number of animals per group required to detect a significant difference with a large effect size (Cohen's d > 0.8), expected on the basis of our prior experiments [16] .
Silencing the PL-pDMS pathway and PL-NAc pathway Test data were analyzed according to planned orthogonal contrasts controlling the Per Contrast Error Rate at a = 0.05 designed to test the hypothesis that Group hM4D+CNO would fail to show significant outcome devaluation relative to the two control groups. These contrasts tested for the main effect of group (Group hM4D+CNO versus rest), main effect of devaluation (Valued versus Devalued) and the interaction, determining whether the devaluation effect in Group hM4D+CNO was significantly less than that observed for the two control groups. Post hoc pairwise tests were conducted according to Fisher's PLSD to follow up any significant interaction.
Silencing the bilateral IT PL-pDMS pathway Test data were initially analyzed according to planned orthogonal contrasts controlling the Per Contrast Error Rate at a = 0.05 designed to test the hypothesis that Group BILATERAL would fail to show significant outcome devaluation relative to the two control groups. These contrasts tested for the main effect of group (Group BILATERAL versus rest), main effect of devaluation (Valued versus Devalued) and the interaction, determining whether the devaluation effect in Group BILATERAL was significantly less than that observed for the other three groups. A second set of contrasts tested whether Group IPSI showed any evidence of an impairment, via testing for a significant Group x devaluation interaction between Group IPSI and Group VEH and also between Group IPSI and Group BILATERAL. Post hoc pairwise tests were conducted according to Fisher's PLSD to follow up a significant interaction. Minute by minute data from the two test sessions from Group BILATERAL were analyzed to determine whether the failure to detect a difference could be attributed to their low baseline response rate. Data were analyzed according to a linear trend (within subjects), to assess whether there had been a significant reduction in overall response rate from the start of Test 1 until the end of Test 2.
Response rates were then compared on valued versus devalued levers at each time point in the trend, to assess whether a significant difference in responding on valued versus devalued levers could be detected at any point across test. Finally, a subset of rats from Group IPSI and Group BILATERAL, matched on response rate during instrumental training, were assessed for outcome devaluation. We removed the highest responders (more than half a standard deviation above the mean on Day 2) from Groups IPSI and the lowest responders (more than half a standard deviation below the mean on Day 2) from Group BILATERAL. Individual pairwise comparisons between responding on devalued and valued levers for each group were conducted using two-tailed t tests.
